Is the HPV Vaccine Worth the Risk?
Researchers are finally raising serious questions as to whether the HPV vaccine is really worth the risks involved. An editorial in the latest issue of the New England Journal of Medicine (NEJM) outlines the rising concerns.
First, Gardasil's long-term effectiveness is unclear. And because cervical cancer takes years to develop, critics say the current information is insufficient to determine whether Gardasil works. Then there’s the issue of side effects. FDA records reveal that, since Gardasil's approval, nearly 9,000 girls had adverse side effects after receiving their shots.
If you’ve been a regular reader of my newsletter, you’ll have noticed that each time I cover another article on HPV, the body count for adverse side effects from this vaccine has risen by several hundred or more… For example, on June 24th, I reported there were more than 6,700 adverse effects reported. Two months later, almost to the day, the Association of American Physicians and Surgeons state 8,864 reports have been filed.
Folks, this is a major CLUE!
Along with NEJM, the organization Judicial Watch has also published a damaging Special Report about the Gardasil vaccine. Based on records obtained under the Freedom of Information Act (FOIA), they summarized the approval process, side effects, safety concerns, and marketing practices related to the human papillomavirus (HPV) vaccine, calling it a “large-scale public health experiment.”
One of their most startling findings was the incidence of 78 cases of outbreaks of warts following the vaccination in women already infected without knowing it. In addition to genital warts, some women experienced large outbreaks on their face, hands, or feet.
Additionally, Gardasil was found to have an efficacy rate of –44.6% (that’s a minus sign) in women already exposed to the HPV types included in the vaccine!
Judicial Watch also uncovered that Gardasil was tested against an aluminum-containing placebo, rather than a nonreactive saline base, which can make the vaccine appear safer than it actually is – which appears to be the case, if you ask me.
The Insanity Continues
Despite all the risks uncovered and the skyrocketing incident reports of harm, vaccine proponents want to move on to the next frontier: older women, and young boys.
Dr. Raffle, a British cervical cancer specialist said it best: “Oh, dear. If we give it to boys, then all pretense of scientific worth and cost analysis goes out the window.”
I believe the mere suggestion already goes to show that this vaccine is nothing more than a cash-cow, offering little proof of any benefits whatsoever, especially considering how easily cervical cancer can be prevented without it.Be wise and be well,
Dr. Jean-Marc
No comments:
Post a Comment